Belumosudil

Clinical trials for Belumosudil explained in plain language.

Never miss a new study

Get alerted when new Belumosudil trials appear

Sign up with your email to follow new studies for Belumosudil, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Which drug tames liver Graft-Versus-Host disease better? a trial puts two to the test

Disease control Recruiting now

This trial compares two oral drugs, belumosudil and ruxolitinib, for treating liver graft-versus-host disease (cGVHD) that does not respond to steroids. The study enrolls people who had a stem cell transplant and now have liver cGVHD. Some participants are randomly assigned to on…

Matched conditions: BELUMOSUDIL

Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Belumosudil

Get alerted when new Belumosudil trials appear

Which drug tames liver Graft-Versus-Host disease better? a trial puts two to the test